J. James Thimons, OD, FAAO, ABO

All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.

A poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.